Verbeeck, Roger K, et al. “The Lidose Hard Capsule Formulation of Fenofibrate Is Suprabioavailable Compared to the Nanoparticle Tablet Formulation Under High-Fat Fed Conditions”. Journal of Pharmacy & Pharmaceutical Sciences, vol. 18, no. 1, Feb. 2015, pp. 61-67, doi:10.18433/J3FG7G.